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Temporal dynamics of intradermal 
cytokine response to tuberculin 
in Mycobacterium bovis 
BCG‑vaccinated cattle using 
sampling microneedles
Sabine Steinbach1,12, Sasan Jalili‑Firoozinezhad2,3,12, Sreenidhi Srinivasan5,12, 
Mariane B. Melo2,3, Sonya Middleton1, Timm Konold6, Michael Coad1, Paula T. Hammond2,7, 
Darrell J. Irvine2,3,8,9,10*, Martin Vordermeier1,11* & Vivek Kapur4,5* 
Bovine tuberculosis (bTB) is a disease of livestock with severe and worldwide economic, animal 
welfare and zoonotic consequences. Application of test‑and‑slaughter‑based control polices reliant on 
tuberculin skin testing has been the mainstay of bTB control in cattle. However, little is known about 
the temporal development of the bovine tuberculin skin test response at the dermal sites of antigen 
injection. To fill this knowledge gap, we applied minimally‑invasive sampling microneedles (SMNs) 
for intradermal sampling of interstitial fluid at the tuberculin skin test sites in Mycobacterium bovis 
BCG‑vaccinated calves and determined the temporal dynamics of a panel of 15 cytokines and 
chemokines in situ and in the peripheral blood. The results reveal an orchestrated and coordinated 
cytokine and local chemokine response, identified IL‑1RA as a potential soluble biomarker of a positive 
tuberculin skin response, and confirmed the utility of IFN‑γ and IP‑10 for bTB detection in blood‑based 
assays. Together, the results highlight the utility of SMNs to identify novel biomarkers and provide 
mechanistic insights on the intradermal cytokine and chemokine responses associated with the 
tuberculin skin test in BCG‑sensitized cattle.
Bovine Tuberculosis (bTB) is a disease of economic importance in livestock species such as cattle, sheep and 
goats and world-wide in distribution. Bovine tuberculosis can be caused by any member of the Mycobacterium 
tuberculosis complex including M. tuberculosis (the main causative agent of TB in humans), although in many 
countries such as the United Kingdom, bTB is caused almost exclusively from infection with M. bovis1. The dis-
ease is an important cause of economic losses to livestock production through lost productivity and the cost of 
control programmes, and are estimated to be around US$ 3 billion per  year2. Importantly, bTB has considerable 
zoonotic relevance, as recently highlighted by the World Health Organization (WHO), World Organisation for 
Animal Health (OIE) and the Union against Tuberculosis and Lung  Disease3.
In many high-income countries, bTB is well-controlled or has been largely eliminated by implementation 
of rigorous test-and-slaugher-based approaches based on active surveillance using tuberculin-based skin test-
ing and slaughter of test-positive animals. Various forms of the tuberculin skin test are employed to test cattle. 
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For example, bTB surveilance in the UK is performed with the comparative cervical tuberculin test (CCT, also 
referred to as single intradermal compartive cervical tuberculin test, SICCT) based on the comparative responses 
to intradermal innoculation of a purified protein derative of tuberculin (PPD) prepared from M. avium (avian 
PPD, PPD-A) and PPD prepared from M. bovis (bovine PPD, PPD-B). The inclusion of PPD-A assesses back-
ground sensitisation of animals with, e.g., environmental mycobacteria to increase test specificity. Other tests 
include the single cervical tuberculin test (SCT, also referred to as single intradermal test, SIT) that relies on the 
injection of PPD-B only and is often used as the prescribed test for international trade. Recent developments in 
tuberculin skin testing for cattle include the use of defined skin test antigen preparations to increase test sensitiv-
ity, for example, DIVA tests compatible with BCG  vaccination1, 4–6.
Whilst tuberculin skin testing of cattle has led to the control and eradication of bTB in many countries, few 
 studies7 have aimed to study the temporal development of tuberculin-induced injection skin responses and none 
has evaluated the kinetics of local cytokine and chemokine responses directly at the local sites of PPD injection 
that drive the hypersensitivity reaction development. Such information would not only allow mechanistic insights 
into the development of tuberculin skin test reactivity in bovines, but could also lead to improved diagnostic 
cytokine read-out systems, particularly when local responses can be compared to systemic responses. With 
these objectives in mind, we sought a minimally-invasive method to collect interstitial fluid directly from skin 
test sites, thereby obviating the need for serial biopsies from a large number of animals and minimizing animal 
welfare concerns.
Minimally invasive approaches for skin interstitial  fluid8 (ISF) sampling have emerged that are based on 
compact patches of  microneedles9–14. Microneedle patches are fabricated in various geometries (solid, porous or 
hollow) and materials (glass, metal, silicon or polymer) using microfabrication  techniques15. Here we developed 
microneedle skin patches capable of effectively penetrating bovine skin and sampling ISF through an absorptive 
hydrogel coating. These patches enable ISF sampling in a minimally invasive manner. Applying this technology, 
we obtained serial ISF samples from tuberculin skin test sites on M. bovis BCG-vaccinated calves and established 
chemokine/cytokine kinetic profiles using a recently developed bovine cytokine/chemokine Luminex multiplex 
 array16. Taken together, the results reveal a coordinated pro- and anti-inflammatory cytokine and chemokine 
response during the development of the bovine tuberculin skin test reaction and identify potential biomarkers 
of a positive tuberculin skin test response.
Results
Sampling microneedles can be used for the recovery of skin‑resident biomarkers in cat-
tle. Steel microneedles with a length of 1400 µm were chosen to enable penetration through the cow skin 
epidermis to the underlying  dermis17, and mounted on a Teflon disk for handling (Fig. 1A, upper panels). The 
microneedle array was coated with a biocompatible alginate-based hydrogel to enable sampling of the intersti-
tial fluid at the site of insertion: an alginate/sucrose solution was dried on the microneedle tines, crosslinked 
by addition of calcium solution, and dried as previously  described18. High molecular weight (150–250 kDa) 
alginate was used because of its optimal mechanical and handling  properties9. Sucrose was included to increase 
the mechanical resilience of the alginate layer during insertion into the stratum corneum and to enhance the 
swelling properties of the sampling microneedles (SMNs). Inclusion of Evans blue dye to visualize the coating 
showed that the resulting patches had a conformal layer of alginate spanning the gaps in each microneedle tine 
(Fig. 1A). Trypan blue staining confirmed that alginate/sucrose-coated microneedles efficiently penetrated cow 
skin explants following manual application of the patches (Fig. 1B), The data obtained from skin explant experi-
ments showed that bovine IgG was easily detected (~ 20 ng  ml−1) in microneedle-recovered ISF from cow skin 
explants (Fig. 1C), suggesting that SMNs may enable the detection of intradermal biomarkers in cattle.
Development of in vivo SMN sampling protocols in bovine calves. Since the studies with skin 
explants demonstrated the feasibility of SMNs to sample bovine skin, we next assessed the potential applica-
tion of SMNs to naïve or BCG-immunized calves. Our preliminary studies revealed that SMNs could be readily 
applied with minimal pressure to closely shaved application sites at the sides of the neck of live animals. This pilot 
in vivo experiment also did not reveal any adverse reactions that might be of animal welfare concern. Indeed, 
the animals did not demonstrate any visible reaction to SMN application (data not shown). It was noteworthy 
that the frequent movement of the animals’ heads and neck precluded extended application of the SMNs to the 
typical tuberculin skin test sites in the cervical region of cattle (Site 1 on Fig. 1D) without the need for additional 
restraint. In contrast, application of the SMN closer to the shoulder (site 2, Fig. 1D) enabled in situ maintenance 
of the SMNs for up to 10 min with gentle digital pressure and precluded the need for additional restraint other 
than a crush. Using this approach, pilot investigations were able to easily detect IgG in ISF samples eluted from 
SMN inserted into naïve calves and held in situ for 10 min (data not shown). Since the site of inoculation is 
known to influence the amplitude of the tuberculin skin  response19, we evaluated whether the shift of injection 
and sampling sites from site 1, the standard injection sites for tuberculin skin testing, to site 2 still maintained 
strong skin test reactivity in BCG vaccinated calves. The results showed that the increase in skin thickness at site 
2 was numerically but not statistically lower compared to PPD-B induced reactivity at site 1 (Fig. 1E). Thus, for 
subsequent studies in BCG-immunized cattle calves, tuberculin tests were performed at site 2 and SMNs applied 
to the same site for 10 min to temporally sample ISF from the area of the developing skin test reaction.
Temporal development of cytokine/chemokine profiles in ISF samples from tuberculin skin test 
sites in BCG‑immunized cattle. To determine the dynamics of the cytokine/chemokine response in ISF 
samples collected via SMN, a Luminex-based bovine cytokine/chemokine array detecting 15 bovine cytokines 
and chemokines was applied. From this assay, 7 cytokines and chemokines (IL-1α, IL-6, IL-1RA, IFN-γ, IL-2, 
3
Vol.:(0123456789)
Scientific Reports |         (2021) 11:7074  | https://doi.org/10.1038/s41598-021-86398-6
www.nature.com/scientificreports/
IP-10, CCL2) were detected in the ISF of BCG-immunized calves (Fig. 2A–G). With the exception of IL-1α 
each of these cytokines and chemokines exhibited a statistically significant (P < 0.05) increase in levels in the 
ISF post-tuberculin injection. The results suggest a coordinated response consisting of induction of early (T24) 
and sustained (T48, T72) pro-inflammatory cytokine responses; IL-6 showed rapid and sustained expression 
compared to pre-injection levels and we observed a strong, yet statistically not significant trend  (PT24 = 0.557, 
 PT48 = 0.257 and  PT72 = 0.296 relative to T0) of increased IL-1α (Fig. 2A,E), each of which is potentially modulated 
by the early and sustained (T24 through T72) induction of the anti-inflammatory cytokine IL-1RA (Fig. 2B). We 
further observed a rapid (T24) and significant induction post-tuberculin injection of the chemokines CCL2/
MCP1 and IP-10/CXCL10 (P < 0.05; Fig. 2D,G). Both chemokines were induced early post PPD-B at T24, but 
IP-10 peaked at T48 and reverted to pre-PPD-B injection levels at T72 (Fig. 2G). Interestingly, a similar pattern 
was also observed for IFN-γ whose detection peaked at T24 and decreased towards pre-injection levels by T72 
(Fig. 2F). Finally, the results show significant amounts of IL-2 detected at all three post-injection time points 
(P < 0.05; Fig. 2C). None of the other cytokines and chemokines part of the multiplex array (IL-1β, IL-4, IL-8, 
IL-10, IL-17A, CCL3 (MIP-1α), CCL4 (MIP-1ß), TNF-α) were detectable above the assay limit of quantification 
(not shown).
To establish whether these local cytokine/chemokine responses were also reflected by a systemic blood 
response, whole blood cultures (harvested at weeks 0 (pre-vaccination) and 5 post-BCG vaccination (prior to 
PPD-B injection)) were stimulated in vitro with PPD-B, with Pokeweed Mitogen (PWM) as a positive control. 
The cytokine/chemokine responses were determined in plasma supernatants using the bovine 15 plex array 
described above. Statistically significant increases post-vaccination were detected for IL-1α, IL-1RA, IFN-γ IL-2, 
IP-10 and TNF-α (P < 0.05, Fig. 3A-D, F, G). IL-6 production was also increased post-vaccination although its 
plasma level increase did not reach statistical significance (Fig. 3E). In contrast, no, or only sporadic and insig-
nificant antigen-specific IL-1β, IL-4, IL-10, or IL-17A responses were detectable (data not shown). Responses 
to CCL2, CCL3, CCL4 and IL-8 could not be measured in plasma due to high levels of interference (data not 
shown). To conclude, the cytokine/chemokine profiles at the skin sites of PPD-B injection are largely reflected 
Figure 1.  Sampling microneedles enable biomarker analysis from skin explants. (A) Medical grade stainless 
steel microneedle patch (top left) was attached to a PTFE/Silicone support (top right; Scale bar 3 mm) 
and coated with alginate-based hydrogel (bottom; inset shows the accumulation of alginate in the needle 
grooves; Scale bar 200 µm). Alginate was mixed with Evans blue dye for better visualization. (B) Trypan blue 
staining post-application confirmed that sampling microneedles efficiently penetrated skin explants. (C) IgG 
concentration as quantified from ISF collected by sampling microneedles. Data shown are means ± SD from 
one representative of two independent experiments. MN: Sampling microneedle; MN (1:10): Collected ISF was 
diluted 1:10 in PBS; Ctrl: Sampling microneedle before skin insertion. Statistical analysis: Kruskal–Wallis with 
Tukey’s multiple comparison test relative to the Ctrl value: *, P < 0.05; **, P < 0.005. (D) Schematic illustration of 
Site 1 (standard side to inject PPD during single cervical tuberculin test on young calves) and Site 2 (site of SMN 
application) on the neck of vaccinated calves. (E) PPD-B induced skin test reactivity on site 1 and site 2 of five 
BCG vaccinated calves. Data expressed as increase in reaction size (mm) 82 h following PPD-B injection.
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in the PPD-B stimulated blood responses, with the exception of TNF-α which was not detected in ISF obtained 
from SMNs.
Figure 2.  Kinetics of cytokine/chemokine profile in ISF collected from skin test sites of BCG vaccinated calves. 
ISF was collected prior to (T0) and 24, 48, and 72 h after injection of PPD-B (T24, T48, T72). Cytokine and 
chemokine content in ISF was determined using a bovine multiplex array via Luminex. Each dot represents the 
results of individual animal, with bars indicating median responses. Statistical analysis: Kruskal–Wallis with 
Dunn’s multiple comparison test relative to the T0 values: *, P < 0.05; **, P < 0.005.
Figure 3.  Cytokine and chemokine profiles in whole blood cultures of BCG vaccinated calves before and 
5 weeks post-vaccination. Whole blood samples were collected at weeks 0 and 5 post-BCG vaccination and 
stimulated with PPD-B, PWM or left unstimulated. Cytokine and chemokine profiles were determined using a 
Luminex-based multiplex array. Each dot represents responses of individual animals with bars indicating mean 
responses. Statistical analysis: Paired two-tailed t-test: *, P < 0.05; **, P < 0.005; compared to week 0.
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Discussion
Interstitial fluid contains a variety of disease- and immune status-associated molecular  biomarkers20, 21. A 
microneedle-based platform can be utilized to sample skin ISF in a pain-free manner, from several hundred 
microns under the skin surface, where only a few capillary beds and pain receptors reside in the connective 
tissue dermis. We here explored this promising sampling approach in order to begin to characterize functional 
aspects of cytokine and chemokine infiltrates, and also accurately monitor temporal immune reactions at the 
dermal sites of tuberculin PPD injection to unravel key tissue-resident immune biomarkers to help improve bTB 
 diagnosis13. Data thereby generated not only provide mechanistic insights into the way bovine tuberculin skin 
test reactions develop but these data could also play an important role in the identification of novel diagnostic 
biomarkers for accurate diagnosis.
Immune monitoring approaches in humans and animal models primarily rely on peripheral blood analysis, 
which can fail to report on the status of major immune cell populations, chemokines and cytokines localized 
in peripheral tissues including barrier tissues such as the  skin22, 23. Skin ISF has been mostly overlooked despite 
containing a variety of disease- and immune status-associated  biomarkers20, 21. While in this study we concen-
trated on collecting ISF, in small animal models, collection and functional characterization of skin resident T 
cell population has been  demonstrated9. This, however, required the SMN to be in contact with the dermis for 
extended periods (hours) in contrast with the 10-min contact time used in the current study on calves. Such 
extended SMN-skin contact periods in large animals can be more challenging, especially because restraining the 
animals for a prolonged duration is a potential animal welfare concern, and hence may require the development of 
alternative approaches to ensure the SMNs remain in situ in unrestrained animals through future studies focused 
on an improved SMN design that enables cell sampling. Apart from sampling skin sites, the microneedles can 
also be modified to deliver diagnostic antigens. Pilot data suggest that peptide antigens bound to microneedle 
patch design will be quickly eluted after the needles had been applied to cow skin (unpublished data).
The current study is the first to describe the kinetics of cytokine/chemokine responses in ISF sampled directly 
from bovine tuberculin skin test sites. To bring these cytokine and chemokine profiles into context with other 
time-course data generated during the development of tuberculin skin test reactions is made challenging due 
to a relative paucity of prior literature. However, a study by Doherty et al. in the late 1990s, applying immuno-
histochemistry approaches to define the cellular subsets in skin biopsies taken during the 72 h post-PPD injec-
tion, provides some context and their findings are summarised in Fig. 4A7. They documented a complex and 
coordinated kinetic of cell populations following tuberculin injection: early (within first 5–12 h) influx of γδ T 
cells expressing WC1 but not CD8, as well as early accumulation of neutrophils followed later (between 36 and 
72 h) by accumulation of CD4 + T cells and macrophages, both reaching their maximum levels at the 72 h sam-
pling point. Interestingly, they also showed evidence of a role for a second γδ T cell population (WC1-CD8+), 
increasing in the reaction sites from 24 h onwards and reaching their maximum level at the end of the observa-
tion period at 72 h post-PPD-B injection (Fig. 4A). Similarly, in the current study cytokine/chemokine profiles 
post-tuberculin injection is also indicative of a coordinated and choreographed response kinetic (Fig. 4B) that 
can be reconciled with the cellular composition data in Fig. 4A. It was observed that IP-10 and CCL2 levels rise 
at T24, peak at T48 and then decline at T72. As both have roles in supporting the recruitment of macrophages/
Figure 4.  Schematic representation of the kinetics of cellular accumulation (A) and cytokine/chemokine 
profiles (B) in bovine tuberculin skin test reaction. (A) Cellular compost profiles according to Doherty 
et al7. Cell subset accumulation was scored from 0 to 4 (maximum response) and is expressed as heat map. 
(B) Biomarker profiles established in the present study are expressed as heat-map based on the maximum 
expression (100%) of each chemokine and cytokine represented.
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monocytes from the vasculature (CCL2) and activate T cells and macrophages (IP-10), their accumulation in skin 
test sites at T24 and later is likely to be instrumental in the recruitment of T cells and macrophages as described 
by Doherty et al. The sustained expression of pro-inflammatory cytokines like IL-6 whose functions include 
T cell and macrophage activation, is also likely to enhance the T cell and macrophage activity involved in this 
delayed-type hypersensitivity (DTH) tuberculin-induced reaction. Interestingly, IFN-γ levels peaked already 
at T24 and then decreased to almost pre-injection levels at T72. This could suggest that this early peak of this 
important cytokine might not be solely caused by  CD4+ T cells as they only start to accumulate in the reaction 
sites by 48 h and later post-tuberculin injection, although the level of cytokine production per individual cell 
will also depend on its activation status. Highly activated tissue-resident  CD4+ T cells could also explain this 
early peak of IFN-γ responses. Alternatively, it is also conceivable that this rapid increase in IFN- γ levels at T24 
is due to its production by the first wave of γδ T cells accumulating rapidly after tuberculin injection (Fig. 4A). 
Another possible source of IFN-γ production could also be Natural Killer (NK) cells, whose presence in skin 
test sites was not assessed by Doherty et al. The increased and sustained prediction of IL-2 at T24 to T72 is also 
indicative of on-going T cell activation and proliferation.
We also found evidence for a mechanism to limit/control the inflammatory responses in the skin test sites as 
we found increased levels of the anti-inflammatory cytokine IL-1RA from T24 to T72. Doherty et al., speculated 
on a regulatory role in limiting the inflammation of the second γδT cell population (WC1-CD8 +) that started 
to accumulate in the skin test sites from 24 h post-PPD-B injection onwards (Fig. 4A). Although they could not 
demonstrate this directly, it is a plausible explanation as bovine γδT cells can carry T regulatory cell  functions24, 25. 
Interestingly, antigen-specific IL1RA gene expression had been recently documented by Palmer et al. in whole 
blood cells from calves infected with M. bovis26, and the present study is the first to report PPD-specific IL-1RA 
production at the protein level locally and systemically. This analyte could constitute a useful novel diagnostic 
biomarker suitable for bTB blood tests. We did not detect increased levels of TNF-α, which is a cytokine com-
monly associated with DTH reactions in bovine tuberculin reaction sites. We compared the local cytokine/
chemokine profiles with responses induced in vitro before and 5 weeks after vaccination and demonstrated that 
the local response profiles were almost completely reflective of systemic blood cell responses with the exception 
of TNF-α which we could only demonstrate in PPD-B stimulated whole blood cell cultures.
Studies on transcriptional profiling of human tuberculin (Mantoux) skin reactions has shown dominant 
expression of genes associated with T cell activation and recruitment. In addition, systemic responses in humans 
were also reflected in those observed at skin test reaction sites. Innate immune gene expression characterised 
by chemokines were detected including CCL2 and IP-10 that were also featuring prominently in our  study27–29. 
However, unlike the present study, they did not report anti-inflammatory IL-1RA responses potentially regulating 
and limiting the tissue damage and inflammation in the tuberculin skin test reaction sites in cattle.
Our studies showed several cytokines and chemokines that remained undetectable (or were only infre-
quently detected and at low concentrations so as to preclude statistical analyses) in blood and interstitial fluid, 
in particular IL-1β, IL-4, IL-10 and IL-17A. In addition, CCL3 and CCL4 had high plasma background levels 
even prior to vaccination and in the absence of stimulus and hence precluded analysis of BCG vaccination or 
antigen-specific responses. The failure to detect an IL-4 response is consistent with previous findings in naturally 
infected  cattle30. Indeed, in a previous study in calves, an increased post-M. bovis infection expression of the splice 
variant IL-4δ833, an IL-4 antagonist, which presumably contributes to a stronger TH1 responses was  noted31. 
IL-10 responses have been described post-infection of cattle. However, the amount of PPD-specific IL-10 was 
associated with reduced skin test activity and disease  progression32. Since BCG vaccination likely results in non-
pathogenic outcomes in cattle, perhaps the failure to detect measurable levels in ISF samples of this cytokine in 
the current studies is consistent with IL-10 being a marker of disease progression but not immunity or protection.
Interleukin-1 induction is a signature response of trained innate immunity post-BCG  vaccination33 in humans 
and small animal models and is consistent with our detection of IL-1α both in blood and ISF in the present study. 
In contrast, the absence of IL-1β both in ISF and the whole blood cultures stimulated with PPD was unexpected 
as this cytokine has previously been considered as a potential biomarker for bovine tuberculosis  diagnosis30 as 
well as shown to be elevated with positive tuberculin skin test in naturally infected  cattle32. While IL-1β responses 
following BCG vaccination in cattle are unknown and require further investigation, the short post-vaccination 
period between vaccination and sampling the animals may also have resulted in animals not having fully devel-
oped all of the features of trained immunity.
Expression of IL-17A has been described in several studies as correlate of protection post-vaccination, with 
strong responses observed in animals vaccinated with BCG/adenoviral heterologous prime-boost  approaches34 
or genetically improved BCG  strains35. Furthermore, increased expression of IL-17A has also been described as 
biomarker of M. bovis infected  cattle36, 37. However, the detection of IL-17A protein has been shown to be less 
sensitive than detection of its transcript, particularly post-BCG  vaccination38. In contrast, antigen-specific IL-
17A protein can be more readily detected post-infection38, 39. Hence, the infrequent and only low level detection 
of antigen-specific IL-17A in the current study in whole blood cultures from BCG vaccinated animals is not 
altogether unexpected, and additional studies in M. bovis infected cattle are warranted to better define the role 
and potential of this and other cytokines as a potential biomarker using the SMN approach.
In conclusion, the results of our investigations suggest that the minimally invasive microneedle-based sam-
pling approach enables characterization of chemokine and cytokine profiles in ISF from the dermal reaction 
sites in BCG-vaccinated cattle. Despite the limitations of being a proof-of-concept study with small sample sizes 
and findings that need to be confirmed in TB infected cattle, the results reveal an orchestrated and coordinated 
cytokine and local chemokine response and provide mechanistic insights on potential local regulation of skin 
test inflammation in response to tuberculin. The identification of IL-1RA as a potential diagnostic blood test 
biomarker and confirmation of the utility of biomarkers such as IFN-γ and IP-10 for bTB detection in blood-
based assays suggest that the SMN approach may be of utility in future investigations for defining key immune 
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signatures associated with the development of the Type IV response to tuberculin in cattle and for discovery and 
validation of novel biomarkers for improved bTB diagnosis.
Methods
Fabrication of sampling microneedles. The solid metal microneedle patch (AdminPatch 1500, Admin-
Med, NanoBiosciences LLC, California, USA) has 31 needle tines, each 1400  µm in length, distributed as a 
diamond shape on a 1  cm2 circular area. The entire patch is 20 mm in diameter and is fabricated from medical 
grade stainless steel. A custom-made PTFE/Silicone (Septa 27236, Sigma) support was attached to the back of 
each microneedle patch using a super glue for ease of handling and to promote uniform insertion of needles 
into skin samples. To generate SMN patches, needles were functionalized with an alginate-based hydrogel coat-
ing as described  previously10. In brief, after oxygen plasma treatment (10 min, 18 W oxygen plasma produced 
by a PDC-32G plasma cleaner), 200 µl of a 0.01 wt% solution of poly(L-lysine) (150–300 kDa, Sigma, P4832) 
was pipetted and dried onto each microneedle to form an adsorbed layer that will subsequently facilitate elec-
trostatic adhesion of the alginate hydrogel. A volume of 200 µl of alginate solution (1.16 mg of alginate (MW: 
150–250 kDa, Viscosity: 100–300 mPa.s, G/M Ratio: ≥ 1, Endotoxins: ≤ 100 EU/g; PRONOVA SLG100, FMC 
BioPolymer) and 4.66 mg of sucrose (Sigma) in 200 µl of water) was pipetted onto each microneedle array and 
air dried at 25 °C for at least 4 h. Finally, 200 µl of crosslinking solution (20 mM  CaCl2) was pipetted onto each 
patch and dried at 25 °C for at least 12 h. To visualize the sampling layer, alginate was mixed with 10 µl of Evans 
blue dye (10 mg/ml, Sigma) before coating the microneedle array.
SMN application to bovine skin tissue explants. Skin tissue samples from the neck region (same as 
tuberculin injection site) of animals were obtained from an USDA-inspected slaughterhouse in Central Penn-
sylvania. The tissue was briefly washed with 70% ethanol on site and then transported in PBS (on ice) to the 
laboratory. Upon arriving in the laboratory, tissue was preserved in DMEM (with Penicillin–Streptomycin) 
at 4 °C until use. After shaving the skin explants, SMNs were pressed onto explanted skin by applying gentle 
digital pressure, and adherence maintained using 3 M Nexcare waterproof tape. Treated skin was stained with 
trypan blue for needle penetration. After 30 min at 37 °C, SMNs were gently removed from the skin explant and 
immersed in 200 µl of PBS containing 100 mM EDTA and incubated at 37 °C on a shaker at 150 rpm for 30 min. 
The supernatant was collected and quantified via enzyme-linked immunosorbent assay (ELISA, R&D Systems, 
DY5930) for immunoglobulin G (IgG).
BCG immunization of bovine calves. Experiments were conducted under a UK Home Office project 
license granted under the Animal (Scientific Procedures) Act and following approval of the experiments by the 
local Animal Welfare and Ethical Review Board. All animal procedures at Animal and Plant Health Agency 
(APHA) were approved by the APHA Animal Welfare and Ethical Review Board (AWERB), in accordance with 
relevant guidelines and regulations, and all authors complied with the ARRIVE guidelines. Calves (3 months old, 
males, Holstein-Frisian or crosses thereof) were sourced from Great Britain herds in the Low Risk Area that were 
Officially TB Free. They were vaccinated via the subcutaneous route with 1–4 ×  106 CFU BCG Danish SSI strain 
1331 (AJ Vaccine, Copenhagen, Denmark). Blood samples were drawn prior to vaccination and 6 weeks after 
vaccination. Skin testing and collection of ISF by SMNs were performed 6 weeks post-vaccination.
Single cervical tuberculin skin test (SCT) and sampling procedure. PPD-B (3000 IU/ml, Thermo 
Fisher, Schlieren, Switzerland) was injected intradermally in the standard SCT site (site 1, Fig. 1D) on the neck 
of vaccinated calves and increases in skin reaction measured 72 h later. At the time of SCT injection, the same 
amounts and volumes of PPD-B were injected into site 2 (Fig. 1D) on both sites of the neck. These sites were 
sampled by applying sampling microneedles for 10 min. Prior to PPD-B injection, sites to be sampled were 
shaved closely. The animals were randomly placed into two groups of 5 calves. One group was sampled by apply-
ing the SMNs to site 2 on one side of the neck without PPD-B injection (T0), and to site 2, which received PPD-B, 
on the other side of the neck, 48 h following PPD-B injection (T48). The second group of calves was injected with 
PPD-B into site 2 on both sides of their necks, and sampled in the same way 24 and 72 h post tuberculin injection 
(T24, T72), ISF was eluted from the SMNs as described above. This injection protocol was set up to ensure that 
each animal was only sampled once on each site with microneedles. The pilot study demonstrated that the SMNs 
would not stay in the skin unless some sort of pressure was applied throughout the sampling time.
Interferon‑gamma release assay (IGRA). Heparinised blood was collected and aliquots of 0.25 ml were 
plated in 96-well plates. Antigen (0.025 ml/well) was added, namely, bovine PPD (PPD-B, final assay concentra-
tion 300 IU/ml), avian PPD (PPD-A, final assay concentration 250 IU/ml), Pokeweed Mitogen as positive con-
trol (final assay concertation 10 µg/ml) and a no antigen (medium only) control for 20 h at 37 °C in the presence 
of 5%  CO2, following which cell supernatants were removed and stored at − 80 °C until required. Quantifica-
tion of IFN-γ in whole blood culture supernatant was determined using the commercially available BOVIGAM 
enzyme-linked immunosorbent assay (ELISA) kit (Thermo Fisher, USA). Results were expressed as the optical 
density at 450 nm  (OD450) for cultures stimulated with bovine tuberculin PPD (PPD-B) and the  OD450 for cul-
tures without antigen.
Bovine cytokine/chemokine multiplex assay. Cytokines/chemokines in interstitial fluid and plasma 
samples were quantified using a bovine customized multiplex (MILLIPLEX MAP Custom Bovine Cytokine/
Chemokine Magnetic Bead Premixed 15 plex Panel, Merck Millipore, UK) assay  kit16. Plasma and EDTA-free 
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(after buffer exchange using Zeba Spin Desalting Columns, Thermo Fisher) interstitial fluid samples were 
thawed, mixed and centrifuged at 1000  g for 10  min. After dilution of plasma (1:2 and 1:10 in assay buffer 
provided in the kit) and interstitial fluid [1:2 in RPMI 1640/20% FCS (Gibco Life Technologies, UK)] 25 µl of 
each sample were processed in duplicates (interstitial fluid) or two different dilutions (plasma) according to 
the manufacturer’s instruction and analysed on Luminex 200 to determine IL-1α, IL-1β, IL-1RA, IL-2, IL-4, 
IL-6, IL-8, IL-10, IL-17A, IFN-γ, TNF-α, CCL2 (MCP-1), CCL3 (MIP-1α), CCL4 (MIP-1ß) and CXCL10 (IP-
10). Belysa immunoassay curve-fitting software was used to calculate concentrations from Median Fluorescent 
Intensity (MFI) data. Only values ≥ lower limit of quantification (LLoQ; determined by the software) are shown 
in the graphs. For interstitial fluid samples the total amount of cytokine was calculated by using the final sample 
volume obtained by elution from sampling microneedles.
Statistical analysis. Statistical analysis was undertaken using Prism v7 (GraphPad San Diego, CA, USA). 
IGRA and blood cytokine responses were analysed by paired two-tailed t-tests. Skin test responses between sites 
1 analysed by Mann–Whitney U test (two-tailed). Temporal development of cytokine and chemokine responses 
in ISFs were assessed using the two-tailed Kruskal–Wallis test with Dunn’s post- test application. Significance 
level (alpha) was set at 5%.
Data availability
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary 
Materials. Additional data related to this paper may be requested from the authors.
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